Healthcare Industry News:  cardiac monitor 

Devices FDA Monitoring

 News Release - September 18, 2006

FDA Approves Lechnologies' AfibAlert(TM) Atrial Fibrillation Monitor

MILWAUKEE--(HSMN NewsFeed)--Sept. 18, 2006--Lechnologies Research Inc. today announced that the U.S. Food and Drug Administration has approved the AfibAlert(TM) Atrial Fibrillation Monitor, a health-care provider prescribed ambulatory cardiac monitor for improved atrial fibrillation management. This lightweight, pocket-sized monitor is an ideal tool for the more than 2 million Americans who suffer from atrial fibrillation (AF), an erratic heart rhythm.

"The AfibAlert(TM) is an innovative monitor for patients with AF because they get immediate, visual feedback from their test," said Tim Lohman, Lechnologies president and CEO. "The AfibAlert(TM) monitor is designed for testing on demand. The AfibAlert(TM) monitor is also a vital tool for health care providers because it captures and records vital diagnostic information - an electrocardiograph (ECG) reading -- that is easily transmitted to them for analysis," Lohman explained.

The AfibAlert(TM) monitor uses a proprietary computer algorithm to monitor for the presence of atrial fibrillation. To operate, the patient holds the small monitor with their hands, placing their thumbs on the raised pads. Each ECG test takes 45 seconds to complete and record. Testing also can be done using wristbands. When testing is complete, a red or green icon illuminates to indicate what action the user should take. The AfibAlert(TM) monitor stores the ECG data using a Cascading Memory(TM) system. As each new recording is taken, the oldest recording is discarded and the five most recent are saved. Patients transmit the latest recording(s) via the telephone or Internet so their health care provider can make informed decisions about treatment.

The AfibAlert(TM) Atrial Fibrillation Monitor is for patients who experience symptomatic or asymptomatic atrial fibrillation, who have a history of ablation, heart bypass surgery, or are taking certain heart medications.

According to the Centers for Disease Control and Prevention's atrial fibrillation (AF) fact sheet, AF is the most common sustained heart rhythm disorder and increases the risk for heart disease and stroke, both leading causes of death in the United States. Atrial fibrillation occurs when the top right chamber of the heart quivers and causes a rapid and irregular beat. People suffering from AF may experience serious complications, even death, according to the CDC. The CDC advises patients to contact a healthcare professional immediately if they experience a rapid or irregular heart rate.

To view an image of the AfibAlert(TM) Atrial Fibrillation Monitor please visit (www.afibalert.com/news-room/).

Note: Federal law restricts the AfibAlert(TM) Atrial Fibrillation Monitor to sale by or on the order of a health care professional.

About Lechnologies' Atrial Fibrillation Business

The atrial fibrillation business (www.afibalert.com) and the AfibAlert(TM) Atrial Fibrillation Monitor is Lechnologies Research's most recent innovation and response to a patient's need for an easy-to-use monitor.

About Lechnologies Research

Lechnologies Research, Inc. (www.lechnologies.com), based in Milwaukee, is a privately held cardiac monitor manufacturer. Lechnologies is dedicated to providing high quality, fast, effective, and affordable cardiac recording and monitoring tools.


Source: Lechnologies Research

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.